AK2 Antibacterial Synthetic Peptide Can Potentiate Macrophage Responses

Document Type : Original Article

Authors

1 Immunoregulation Research Center, Shahed University, Tehran, Iran.

2 Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Background: Emphasis on substitutional medications with the elevated bacterial resistance to current antibiotics is pivotal. We evaluated the antibacterial effect of AK2 by Minimum Bactericidal Concentration (MBC) and Minimum inhibitory Concentration (MIC) and its impact on macrophage responses in 17 strains of pathogenic bacteria. The gene expression of macrophage’s cytokines was evaluated. Accordingly, the bioinformatic assessment predicted this peptide’s physicochemical characteristics, behavior, and structures. The present study aimed to assess the antibacterial effect of AK2 peptides on Macrophage responses.
Materials and Methods: Cytotoxicity level was assessed by MTT assay on the HeLa cell line. The hemolytic activity of peptides on red blood cells was evaluated. The Griess assay was performed to assess the amount of macrophage nitric oxide production. The real-time PCR method measured the iNOS, IFN-γ, and TNF-α gene expression in isolated macrophages. 
Results: Peptide concentrations (13-60 µg/mL) were observed as the MBC and MIC value results for various bacteria. No remarkable cytotoxicity was observed at 30 and 60 µg/ml concentrations after 24h. iNOS, IFN-γ, and TNF-α gene expression were upregulated. There was also a higher secretion of nitric oxide in 48 hour-culture of the cell line with peptide. Great antibacterial activity was observed in some bacterial strains, particularly B. melitensis. 
Conclusion: AK2 peptides display suitable antibacterial activity with negligible toxicity for host cells. This peptide could also stimulate macrophage responses through nitric oxide production and gene expression in proinflammatory cytokines. 

Keywords


  1. Fish DN. Optimal antimicrobial therapy for sepsis. American Journal of Health-System Pharmacy. 2002; 59(Suppl 1):S13-9. [DOI:10.1093/ajhp/59.suppl_1.S13][PMID]
  2. Rodríguez-Melcón C, Alonso-Hernando A, Riesco-Peláez F, García-Fernández C, Alonso-Calleja C, Capita R. Biovolume and spatial distribution of foodborne Gram-negative and Gram-positive pathogenic bacteria in mono-and dual-species biofilms. Food Microbiology. 2021; 94:103616. [DOI:10.1016/j.fm.2020.103616][PMID]
  3. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases. 2013; 13(12):1057-98. [DOI:10.1016/S1473-3099(13)70318-9][PMID]
  4. Neu HC. The crisis in antibiotic resistance. Science. 1992; 257(5073):1064-73. [DOI:10.1126/science.257.5073.1064][PMID]
  5. Brogden KA. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nature Reviews Microbiology. 2005; 3(3):238-50. [DOI:10.1038/nrmicro1098][PMID]
  6. Boulanger N, Bulet P, Lowenberger C. Antimicrobial peptides in the interactions between insects and flagellate parasites. Trends in Parasitology. 2006; 22(6):262-8. [DOI:10.1016/j.pt.2006.04.003][PMID]
  7. Malmsten Antimicrobial peptides. Upsala Journal of Medical Sciences. 2014; 119(2):199-204. [DOI:10.3109/03009734.2014.899278][PMID][PMCID]
  8. Chou HT, Wen HW, Kuo TY, Lin CC, Chen WJ. Interaction of cationic antimicrobial peptides with phospholipid vesicles and their antibacterial activity. Peptides. 2010; 31(10):1811-20. [DOI:10.1016/j.peptides.2010.06.021][PMID]
  9. Zasloff M. Innate immunity, antimicrobial peptides, and protection of the oral cavity. The Lancet. 2002; 360(9340):1116-7. [DOI:10.1016/S0140-6736(02)11239-6]
  10. Schindler L, Zwissler L, Krammer C, Hendgen‐Cotta U, Rassaf T, Hampton MB, et al. Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells. Journal of Leukocyte Biology. 2021; 110(5):893-905. [DOI:10.1002/JLB.3A0420-242RRR][PMID]
  11. Faoagali JL. Klebsiella urinary tract infection. The New Zealand Medical Journal. 1975; 81(536):286-8. [PMID]
  12. Kazemzadeh-Narbat M, Cheng H, Chabok R, Alvarez MM, de La Fuente-Nunez C, Phillips KS, et al. Strategies for antimicrobial peptide coatings on medical devices: A review and regulatory science perspective. Critical Reviews in Biotechnology. 2021; 41(1):94-120. [DOI:10.1080/07388551.2020.1828810][PMID]
  13. Loftus RW, Dexter F, Robinson AD. Methicillin-resistant Staphylococcus aureus has greater risk of transmission in the operating room than methicillin-sensitive S aureus. American Journal of Infection Control. 2018; 46(5):520-5. [DOI:10.1016/j.ajic.2017.11.002][PMID]
  14. Kadry A. Lack of efflux mechanism in a clinical isolate ofPseudomonas aeruginosa highly resistant to β-lactams and imipenem. Folia Microbiologica. 2003; 48(4):529-33. [DOI:10.1007/BF02931336][PMID]
  15. Li XZ, Ma D, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: Active efflux as a contributing factor to beta-lactam resistance. Antimicrobial Agents and Chemotherapy. 1994; 38(8):1742-52. [DOI:10.1128/AAC.38.8.1742][PMID][PMCID]
  16. Hancock R, Patrzykat A. Clinical development of cationic antimicrobial peptides: From natural to novel antibiotics. Current Drug Targets-Infectious Disorders. 2002; 2(1):79-83. [DOI:10.2174/1568005024605855][PMID]
  17. Hancock RE. Cationic peptides: Effectors in innate immunity and novel antimicrobials. The Lancet Infectious Disea 2001; 1(3):156-64. [DOI:10.1016/S1473-3099(01)00092-5]
  18. Lavine M, Chen G, Strand M. Immune challenge differentially affects transcript abundance of three antimicrobial peptides in hemocytes from the moth Pseudoplusia includens. Insect Biochemistry and Molecular Biology. 2005; 35(12):1335-46. [DOI:10.1016/j.ibmb.2005.08.005][PMID]
  19. Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the immune system. Critical Reviews in Immunology. 2000; 20(5):407-31. [DOI:10.1615/CritRevImmunol.v20.i5.40][PMID]
  20. Zare-Zardini H, Taheri-Kafrani A, Ordooei M, Ebrahimi L, Tolueinia B, Soleimanizadeh M. Identification and biochemical characterization of a new antibacterial and antifungal peptide derived from the insect Sphodromantis viridis. Biochemistry. 2015; 80(4):433-40. [DOI:10.1134/S0006297915040069][PMID]
  21. Moghaddam MM, Barjini KA, Ramandi MF, Amani J. Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells. World Journal of Microbiology and Biotechnology. 2014; 30(5):1533-40. [DOI:10.1007/s11274-013-1575-y][PMID]
  22. Marr AK, Gooderham WJ, Hancock RE. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Current Opinion in Pharmacology. 2006; 6(5):468-72. [DOI:10.1016/j.coph.2006.04.006][PMID]
  23. Han J, Jyoti MA, Song HY, Jang WS. Antifungal activity and action mechanism of histatin 5-halocidin hybrid peptides against Candida ssp. PloS One. 2016; 11(2):e0150196. [DOI:10.1371/journal.pone.0150196][PMID][PMCID]
  24. Landes MB, Rajaram MV, Nguyen H, Schlesinger LS. Role for NOD2 in Mycobacterium tuberculosis‐induced iNOS expression and NO production in human macrop Journal of Leukocyte Biology. 2015; 97(6):1111-9. [DOI:10.1189/jlb.3A1114-557R][PMID][PMCID]
  25. Locht LJ, Smidt K, Rungby J, Stoltenberg M, Larsen A. Uptake of silver from metallic silver surfaces induces cell death and a pro-inflammatory response in cultured J774 macrophages. Histology and Histopathology. 2011; 26(4):689-97. [DOI:10.14670/HH-26.689][PMID]
  26. Zhang F, Mears JR, Shakib L, Beynor JI, Shanaj S, Korsunsky I, et al. IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation. Genome Medicine. 2021; 13(1):64. [DOI:10.1186/s13073-021-00881-3][PMID][PMCID]
  27. Amirshahrokhi K. Acrylamide exposure aggravates the development of ulcerative colitis in mice through activation of NF-κB, inflammatory cytokines, iNOS, and oxidative stress. Iranian Journal of Basic Medical Sciences. 2021; 24(3):312-21. [DOI:10.22038/IJBMS.2021.52233.11816]
  28. Jang JY, Choi GH, Ji S. IFN‐γ or IL‐4 polarization impacts the response of gingival fibroblasts to oral bacteria. Journal of Periodontal Research. 2021; 56(3):462-70. [DOI:10.1111/jre.12837][PMID]
  29. Almutairi F, Tucker SL, Sarr D, Rada B. PI3K/NF-κB-dependent TNF-α and HDAC activities facilitate LPS-induced RGS10 suppression in pulmonary mac Cellular Signalling. 2021; 86:110099. [DOI:10.1016/j.cellsig.2021.110099][PMID]
  30. Dreschers S, Gille C, Haas M, Seubert F, Platen C, Orlikowsky TW. Reduced internalization of TNF-ɑ/TNFR1 down-regulates caspase dependent Phagocytosis Induced Cell Death (PICD) in neonatal monocytes. PLoS One. 2017; 12(8):e0182415. [DOI:10.1371/journal.pone.0182415][PMID][PMCID]
  31. Nishida M, Yamashita N, Ogawa T, Koseki K, Warabi E, Ohue T, et al. Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes. Journal for Immunotherapy of Cancer. 2021; 9(9):e002954. [DOI:10.1136/jitc-2021-002954][PMID][PMCID]
  32. Park E, Levis W, Greig N, Euisun J, Schuller-Levis G. Effect of thalidomide on nitric oxide production in lipopolysaccharide-activated RAW 264.7 cells. Journal of Drugs in Dermatology. 2010; 9(4):330-3. [PMID][PMCID]
  33. Nathan CF, Hibbs Jr JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Current Opinion in Immunology. 1991; 3(1):65-70. [DOI:10.1016/0952-7915(91)90079-G]
  34. Snyder SH, Bredt DS. Biological roles of nitric oxide. Scientific American. 1992; 266(5):68-77. [DOI:10.1038/scientificamerican0592-68][PMID]
  35. Bogdan C. Nitric oxide and the immune response. Nature Immunology. 2001; 2(10):907-16. [DOI:10.1038/ni1001-907][PMID]
  36. Bogdan C. Nitric oxide synthase in innate and adaptive immunity: An update. Trends in immunology. 2015; 36(3):161-78. [DOI:10.1016/j.it.2015.01.003][PMID]
  37. MacMicking J, Xie Q-w, Nathan C. Nitric oxide and macrophage function. Annual Review of Immunology. 1997; 15(1):323-50. [DOI:10.1146/annurev.immunol.15.1.323] [PMID]